Discover
TT HealthWatch
TT HealthWatch
Author: Texas Tech Health El Paso IA Webmaster
Subscribed: 71Played: 1,845Subscribe
Share
© Texas Tech University Health Sciences Center El Paso. All rights reserved.
Description
Stay up-to-date with the latest research in medicine and science with TT HealthWatch. This 10-minute podcast is hosted by Richard Lange, M.D., M.B.A., president of Texas Tech University Health Sciences Center El Paso and dean of the Paul L. Foster School of Medicine, and Elizabeth Tracey, M.S., Baltimore-based medical journalist.
Each week, Richard and Elizabeth explore recent peer-reviewed studies and breaking medical news, offering a Texas Tech perspective on the latest developments in health care.
50 Episodes
Reverse
Program notes:0:37 HIV treatment monthly injections1:37 Long acting and effective2:37 Some didn't come for monthly injections3:16 COVID-19 vaccination and preeclampsia rate4:16 In two successive cohorts during pandemic5:16 Pre-existing morbidity 58% reduction6:15 COVID-19 cytokine storm?6:45 Monkeypox treatment7:45 Randomized to placebo or smallpox drug8:50 Menstrual blood to test for HPV9:50 Minipad essentially the same as clinician collection10:45 Can make it cost effective?11:49 End
Program notes:0:37 Hormone therapy and mortality1:37 Those who used versus those unexposed2:35 Different types of HT3:32 Adolescent cannabis use and mental illness4:32 Screened in physician office5:32 Action at societal and government levels6:00 Access to dialysis facilities and SES7:01 2.3 % of advantaged communities lacked access8:01 For profit centers consolidate9:01 Roughly half of nephrology spots unfilled9:33 ACOs and Medicare savings10:33 Initial study showed net savings11:16 Fragile savings estimate12:09 End
Program notes:0:35 Diabetes and food prescriptions1:35 Got a food card to purchase nutritious foods2:32 More than half didn't use it or used it less than 60%3:00 Adequacy of a planetary health diet4:00 Micronutrient intake and biomarkers5:00 Doesn't seem to compromise long-term health6:12 Statin recommendations and patient preferences7:00 Benefit/risk analysis for patients8:00 Patient's decisions are multifactorial9:00 Resistance to daily medication9:30 Findings on shoulder MRI10:35 Rotator cuff abnormalities in almost 99%11:35 Almost ubiquitous regardless of symptoms12:25 Physical therapy best strategy13:23 End
Program notes:0:38 Removal of fallopian tubes to prevent ovarian ca1:43 129 studies included2:43 Women who no longer desire pregnancy3:40 Technically feasible4:30 New oral PCSK9 inhibitor5:35 Think it's a slam dunk6:08 EHR helping deprescribing in older adults7:08 Two sequential EHR interventions8:08 40% more likely in one group9:08 Something in email less effective9:50 Benefits of knee braces for OA10:50 Brace specific to area of OA12:00 If it results in a placebo effect13:00 End
Program notes:0:50 Rapid recovery of hearts for transplant after circulatory death1:50 Total ischemic time longer than 4 hours2:50 Typically reanimate3:50 Expanded to donors 40 years of age4:55 Do women with PCOS have increased risk for arrhythmia5:55 Incidence arrhythmia in these women increased risk6:50 An LLM to streamline transitions from primary to secondary care7:50 Used alone, with staff support, or control8:51 Decreased amount of time in the consult9:52 Things that accumulate data will be embraced10:12 Treating gout to prevent CVD11:12 Lowered in about a fourth of patients12:36 End
Program notes:0:45 Impact on kids of parental firearm injury or death1:46 Eight additional psychiatric diagnoses per 100,0002:39 Lifetime stress, inflammation and racial disparities in mortality3:40 Black individuals shorter survival4:40 Precise number is difficult to understand5:40 Self-report6:45 If a woman has known CVD, can she discontinue statins in pregnancy?7:45 No difference in woman's health8:45 Over a 14-year period9:00 Policy compliance in leading tobacco brands10:00 Instagram, FTC and FDA policies11:00 Cut across all types of nicotine products12:59 End
Program notes:0:40 Two MMWR reports on wastewater to detect measles1:40 Subsequent detection after early identification2:40 Watch worldwide transition3:15 Weight regain after medication for weight management4:16 Cardiometabolic risk factors return in just over a year5:16 Willingness to use declined with knowledge of regain risk6:16 Prevention of obesity6:33 Chronic kidney disease and heart failure link7:35 Extracellular vesicles found8:35 Precise identification of a tangle pathway9:03 Physical activity types, varieties and mortality10:03 Higher variety conferred additional survival benefit11:03 Will you change your behavioral?12:03 Lower hypertension, BMI12:39 End
Program notes:0:38 Childhood vaccinations nationally1:30 Across 45 states and DC2:34 Level of vaccine protection3:34 Professional societies stepping in3:51 Skilled nursing facilities 4:51 Estimated operating capacity5:51 Backups into hospitals6:51 Staffing not returned to pre-pandemic levels7:35 Prescribing patterns of CNS active meds in older adults8:36 Several classes of medication examined9:36 Last line medications9:50 Mifepristone regulation historically10:50 Consistent findings on safety11:50 FDA looking at REMS12:50 End
Program notes:0:35 Global pain burden1:35 Prevalence increased in 15 countries2:35 Higher prevalence in older people but not consequence of aging3:02 Tertiary patents4:03 in the Orange Book5:05 Prolonged patent protection and higher prices6:07 Focused on high revenue products6:50 Detecting DVT better7:51 Age specific D-dimer cutoffs8:51 Age and morbidity factors9:23 Infant screen time and adolescent anxiety10:24 Multiple intermediate assessments11:24 Accelerates development12:47 End
Program notes:0:40 IVF clinics and private equity1:40 Provide over 54% of all IVF cycles in U.S.2:41 Perhaps a more positive result3:30 EKGs and liver cirrhosis4:30 New diagnosis of advanced liver disease5:30 Most physicians didn't follow up6:18 Management of acute back pain7:18 Did it improve pain or disability?8:18 Four- to eight-hour-long sessions to teach8:46 Lay health worker led intervention for older adults with cancer9:46 Reviewed with advanced practice practitioners10:46 Huge benefit from modest intervention11:46 Pick up the phone and ask12:20 Modest outlay13:09 End
Program notes:0:40 Saturated fat and CVD1:40 When it was reduced in diet only helped in those with high risk2:40 Obesity, diabetes and metabolic syndrome also important3:30 Diagnostic follow up after lung CT4:30 Less intensive than recommended in non-Hispanic blacks5:31 Herpes antiviral and Alzheimer's6:30 Followed for five years7:30 80-90% of population exposed8:30 Change screening criteria for lung ca9:33 Population based study10:30 Calculating pack years11:20 Rolling out through national organizations12:17 End
Program notes:0:37 Breast density knowledge outcomes1:37 Breast density notification and education2:37 Can't assess the import individually3:30 CV outcomes with tirzepatide4:30 HbA1c 8.45:30 GLP-1s have many benefits6:30 No difference in adverse events7:10 Covid vaccination in pregnancy8:10 20K women included9:10 Initial benefit is it durable?9:30 Complex regional pain syndrome treatment10:30 Using bisphosphonates for treatment11:33 Even light contact causes severe pain12:28 End
Program notes:0:35 Should surgery efficacy1:30 10-year follow of ASD surgery2:30 Exercise does relieve pain3:00 Association of pain with intrinsic capacity and inflammation4:00 Domains including locomotion and others5:01 Pain impacts a number of capacities6:01 Aspirational to figure out pain6:30 Scheduling birth at term to avoid preeclampsia7:30 High-risk pregnancy delivered at term8:35 Is there impact on the infants?9:18 AI decision support for large-vessel stroke10:20 71,000+ patients with ischemic stroke11:25 U.S. data also not impressive12:54 End
Program notes:0:35 Update on RSV, flu and COVID-19 vaccines1:35 500 studies included2:35 Rare myocarditis3:35 Flu vaccine in older adults4:30 Tai chi or CBT-I for chronic insomnia5:30 Trained in one or the other6:30 Inexpensive and accessible7:30 $150 billion cost of chronic insomnia7:45 GLP-1s and WHO guidance8:50 Multimodal approach required9:45 Prevention is important9:55 Corticosteroids in pregnancy10:50 1.3 million pregnancies11:50 Used for multiple indications12:46 End
Program notes:0:40 CVD risk factors and texting1:40 How many undergo screening?2:41 Impact of personalized messaging3:25 Decentralized trials versus centralized 4:25 Decentralized much larger5:25 Does the trial move in one way or another?6:15 Two studies related to use of peripregnancy GLP-1 use7:15 Stopping at pregnancy8:15 Is overweight worse than stopping?9:00 Machine learning model, tissues, genetics and age10:00 Practical for assessing genetic basis11:00 Sequential tissue samples11:57 End
Program notes:1:25 mRNA flu vaccine2:25 Phase three trial3:25 Preventing infection with a respiratory virus4:25 Prophylaxis with NSAID?4:45 Umbrella review of acetaminophen in pregnancy, ASD and ADHD5:42 Confidence was low to critically low6:45 Other factors such as environmental exposures7:22 Increasing potassium to prevent heart arrythmias8:33 Increase with supplements or dietary advice9:18 Canceling funding for clinical trials10:18 In the process of receiving interventions11:18 Can't not analyze 12:15 End
Program notes:0:50 Fish oil supplements and hemodialysis1:50 1200 individuals to fish oil or not2:50 Needs another study3:11 PCSK9 inhibitor in people without MI or stroke4:13 3- or 4-point MACE5:11 Getting LDL down helps6:11 Addition of more than one oral agent6:50 Right therapy for afib and a stent7:50 Noninferiority trial8:50 After 12 months single agent works9:27 Anticoagulation after afib tx10:30 Low primary safety outcomes11:25 96% won't have a stroke12:16 End
Program notes:0:37 An oral med for obesity1:37 Five to 10% stopped medication2:35 Need head-to-head trials with injectable3:00 Stem cell infusion after MI and heart failure4:01 Reduced heart failure in recipients5:01 Twice as many in the control arm6:01 Moving past BMI in predicting atherosclerosis7:01 Especially in overweight but not obese8:01 Almost 3000 participants in Brazil8:25 Blood samples precede MS9:04 Seen seven years beforehand10:02 Twin studies and relatives11:03 Way to intervene earlier11:15 Applaud OpenAI13:00 End
Program notes:0:45 Steps, more and longer?1:45 8,000 steps or less2:45 Nothing on intensity3:30 Mediterranean diet for IBS4:30 Reduction in IBS symptom severity scale5:30 Easy to accommodate with high compliance6:30 Exercise for knee osteoarthritis7:30 All types of exercise examined8:30 Initiated exercise to try to address9:00 AI intervention in prediabetes10:00 Based on diabetes prevention program11:00 AI and human led essentially the same12:00 99% of eligible group don't have access13:09 End
Program notes:0:40 Nicotine reduction for various subgroups1:40 Native American and Alaskan populations benefit most2:42 Black, rural populations 10 million lives saved3:40 19-39 million life years saved4:00 Food insecurity and blood pressure5:00 Food vouchers most successful6:00 May be more involved and motivated6:35 PFAS and infant brain architecture7:35 Children assessed with MRI8:30 Didn't correct for various factors9:31 Other types of plasticized chemicals9:50 Afib after cardiac surgery10:50 Only found with implantable monitor11:50 Very short duration of afib12:51 End




